vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Iridium Communications Inc. (IRDM). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $219.1M, roughly 1.3× Iridium Communications Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 9.9%, a 86.5% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 1.9%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 4.4%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Iridium Communications Inc. is a publicly traded American company headquartered in McLean, Virginia, United States. Iridium operates the Iridium satellite constellation, a system of 80 satellites: 66 are active satellites and the remaining fourteen function as in-orbit spares. Iridium Satellites are used for worldwide voice and data communication from handheld satellite phones, satellite messenger communication devices and integrated transceivers, as well as for two-way satellite messaging se...
ACAD vs IRDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $219.1M |
| Net Profit | $273.6M | $21.6M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 23.2% |
| Net Margin | 96.3% | 9.9% |
| Revenue YoY | 9.4% | 1.9% |
| Net Profit YoY | 90.3% | -29.0% |
| EPS (diluted) | $1.61 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $219.1M | ||
| Q4 25 | $284.0M | $212.9M | ||
| Q3 25 | $278.6M | $226.9M | ||
| Q2 25 | $264.6M | $216.9M | ||
| Q1 25 | $244.3M | $214.9M | ||
| Q4 24 | $259.6M | $213.0M | ||
| Q3 24 | $250.4M | $212.8M | ||
| Q2 24 | $242.0M | $201.1M |
| Q1 26 | — | $21.6M | ||
| Q4 25 | $273.6M | $24.9M | ||
| Q3 25 | $71.8M | $37.1M | ||
| Q2 25 | $26.7M | $22.0M | ||
| Q1 25 | $19.0M | $30.4M | ||
| Q4 24 | $143.7M | $36.3M | ||
| Q3 24 | $32.8M | $24.4M | ||
| Q2 24 | $33.4M | $32.3M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | — | 23.2% | ||
| Q4 25 | 6.1% | 25.9% | ||
| Q3 25 | 12.8% | 30.9% | ||
| Q2 25 | 12.2% | 23.2% | ||
| Q1 25 | 7.9% | 28.1% | ||
| Q4 24 | 59.1% | 24.5% | ||
| Q3 24 | 12.6% | 25.8% | ||
| Q2 24 | 12.6% | 21.7% |
| Q1 26 | — | 9.9% | ||
| Q4 25 | 96.3% | 11.7% | ||
| Q3 25 | 25.8% | 16.4% | ||
| Q2 25 | 10.1% | 10.1% | ||
| Q1 25 | 7.8% | 14.2% | ||
| Q4 24 | 55.4% | 17.1% | ||
| Q3 24 | 13.1% | 11.5% | ||
| Q2 24 | 13.8% | 16.1% |
| Q1 26 | — | — | ||
| Q4 25 | $1.61 | $0.24 | ||
| Q3 25 | $0.42 | $0.35 | ||
| Q2 25 | $0.16 | $0.20 | ||
| Q1 25 | $0.11 | $0.27 | ||
| Q4 24 | $0.86 | $0.30 | ||
| Q3 24 | $0.20 | $0.21 | ||
| Q2 24 | $0.20 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | — |
| Total Assets | $1.6B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | $96.5M | ||
| Q3 25 | $258.0M | $88.5M | ||
| Q2 25 | $253.6M | $79.3M | ||
| Q1 25 | $217.7M | $50.9M | ||
| Q4 24 | $319.6M | $93.5M | ||
| Q3 24 | $155.1M | $159.6M | ||
| Q2 24 | $177.1M | $63.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $462.6M | ||
| Q3 25 | $917.3M | $450.5M | ||
| Q2 25 | $822.4M | $473.6M | ||
| Q1 25 | $765.2M | $518.4M | ||
| Q4 24 | $732.8M | $576.6M | ||
| Q3 24 | $577.2M | $663.8M | ||
| Q2 24 | $516.7M | $786.7M |
| Q1 26 | — | — | ||
| Q4 25 | $1.6B | $2.5B | ||
| Q3 25 | $1.3B | $2.6B | ||
| Q2 25 | $1.2B | $2.6B | ||
| Q1 25 | $1.1B | $2.6B | ||
| Q4 24 | $1.2B | $2.7B | ||
| Q3 24 | $976.9M | $2.8B | ||
| Q2 24 | $914.1M | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.80× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 13.7% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $108.6M | ||
| Q3 25 | $74.3M | $100.8M | ||
| Q2 25 | $64.0M | $129.6M | ||
| Q1 25 | $20.3M | $61.1M | ||
| Q4 24 | $40.4M | $104.8M | ||
| Q3 24 | $63.2M | $118.6M | ||
| Q2 24 | $25.0M | $81.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $75.1M | ||
| Q3 25 | $73.9M | $79.2M | ||
| Q2 25 | — | $108.9M | ||
| Q1 25 | — | $36.5M | ||
| Q4 24 | — | $80.5M | ||
| Q3 24 | $63.2M | $100.0M | ||
| Q2 24 | — | $68.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 35.3% | ||
| Q3 25 | 26.5% | 34.9% | ||
| Q2 25 | — | 50.2% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 37.8% | ||
| Q3 24 | 25.2% | 47.0% | ||
| Q2 24 | — | 34.2% |
| Q1 26 | — | 13.7% | ||
| Q4 25 | — | 15.7% | ||
| Q3 25 | 0.1% | 9.5% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 11.4% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | 0.0% | 8.7% | ||
| Q2 24 | — | 6.2% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 4.37× | ||
| Q3 25 | 1.03× | 2.71× | ||
| Q2 25 | 2.40× | 5.90× | ||
| Q1 25 | 1.07× | 2.01× | ||
| Q4 24 | 0.28× | 2.88× | ||
| Q3 24 | 1.93× | 4.85× | ||
| Q2 24 | 0.75× | 2.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
IRDM
| Voice and data | $57.4M | 26% |
| IoT data (2) | $43.9M | 20% |
| Government | $35.8M | 16% |
| Government service revenue (5) | $26.8M | 12% |
| Subscriber equipment | $23.1M | 11% |
| Hosted payload and other data service (4) | $14.9M | 7% |
| Broadband (3) | $12.9M | 6% |
| Commercial | $1.6M | 1% |
